Clinical Trial Update: A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating autologous ex vivo activated NK cell infusion for metastatic nasopharyngeal carcinoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Autologous ex vivo activated NK cell infusion (autologous ex vivo activated natural killer (NK) cell therapy)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Metastatic Nasopharyngeal | Phase 1 | Status: COMPLETED